Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European organization for research and treatment of cancer genitourinary group (Q31780670)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European organization for research and treatment of cancer genitourinary group |
scientific article |
Statements
1 reference
Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European organization for research and treatment of cancer genitourinary group (English)
1 reference
S D Fosså
1 reference
P H Slee
1 reference
M Brausi
1 reference
S Horenblas
1 reference
R R Hall
1 reference
J W Hetherington
1 reference
N Aaronson
1 reference
de Prijck L
1 reference
L Collette
1 reference
1 reference
Identifiers
1 reference